GFCL's chemicals business is firing on all cylinders. But the real long-term story is its battery materials arm. Management calls it the "next phase of growth" for the company, and it is absorbing most of GFCL's ₹6,000 crore capex plan.
The timing makes this interesting. In the last few months, China has tightened its grip on LFP battery technology. Several large Indian groups, including JSW, Reliance and Amara Raja, have paused, delayed or reworked their cell plans as a result. At the same time, the Indian government is preparing a fresh incentive scheme for battery components.
So is GFCL EV a winner or a casualty of these shifts? Let's break it down.
GFCL reported a strong quarter (April–June 2026), led by fluorochemicals and fluoropolymers. This cash engine is what pays for the battery build-out.
Metric (consolidated) | Q1 FY27 | YoY change | QoQ change |
|---|---|---|---|
| Revenue | ₹1,588 crore | +24% | +16% |
| EBITDA | ₹428 crore | +24% | +39% |
| EBITDA margin | 27% | — | up from 22% |
| PAT | ₹219 crore | +19% | more than doubled |
A few other highlights from the call:
Fluorochemicals revenue rose 52% YoY and 44% QoQ, driven mainly by R32 refrigerant. The existing R32 plant is running at full utilisation, and new capacity is due in Q2 FY27.
Fluoropolymers grew 15% YoY, helped by higher-value grades for semiconductors, data centres and green hydrogen. Management expects 17–20% annual growth.
Return ratios improved. ROCE rose to 16.6% and ROE to 15.18%. Working capital days fell from 192 to 149.
Battery materials revenue is still small, at roughly ₹20–30 crore a quarter.
GFCL is not making battery cells. It makes the chemicals and materials that go inside a cell. That distinction matters for everything that follows.
Product | What it does in a battery | Status per Q1 FY27 call | Main customers |
|---|---|---|---|
| LiPF₆ (lithium hexafluorophosphate) | Salt dissolved in the electrolyte; carries lithium ions | Qualification almost complete; in growth phase | Leading global electrolyte makers |
| PVDF binder | Holds electrode material together | Qualification very close to final | Cell makers |
| Electrolytes | The liquid medium inside the cell | Sampling, audits and plant visits underway | Indian cell makers |
| LFP cathode active material | The positive electrode material in LFP cells | Revenue expected towards end of FY27 | Cell makers |
| Anode active material | The negative electrode material | Announced last quarter; capex not disclosed | Cell makers |
Revenue guidance from management:
About ₹20–30 crore a quarter today. Some Q1 shipments were sent on CIF terms and will be booked in Q2.
Three-digit quarterly revenue (₹100 crore+) by Q4 FY27. Management confirmed this is on track.
A significant ramp-up in FY28. The full potential of the current investment shows from FY28 onwards, because the industry needs about 1.5 years for stabilisation and customer qualification.
Market sizing management is working with: global battery demand of about 1,800 GWh by 2030, and Indian demand of 220–250 GWh by 2030, driven mainly by battery energy storage systems (BESS).
GFCL plans to spend about ₹2,300 crore on the EV business in FY27 alone, out of a total announced plan of ₹6,000 crore. The EV gross block is about ₹836 crore today and should reach about ₹1,200 crore by year-end. Capital work in progress stands at about ₹1,900 crore.
The gap between spending and capitalisation is normal here. A plant is capitalised only when it starts producing material of the right quality, and that timing varies plant to plant.
The Oman switch. GFCL had planned a roughly $216 million battery materials plant in Oman. That project is now on hold and the capacity is moving to India. Management cited geopolitical reasons that were causing delays, and said India lets it move faster and meet customer commitments.
Land is not a constraint. Phase one goes into the existing Dahej B (Jolva) site, which already has approvals and infrastructure. A new Dahej site will be added in late FY27–FY28.
Funding is the catch. About ₹1,200 crore from Oman's sovereign fund (OIA) was approved only for the Oman project, so it won't be available for India. Management says fundraising is already underway and does not see it as a constraint.
Our view: Moving to India is strategically sensible. It speeds up execution and puts the plant inside India's incentive net. But investors should track how the funding gap is filled, whether through debt, internal accruals or equity at the subsidiary level.
China has not banned LFP batteries or LFP material exports. It has put advanced LFP technology under an export licence regime, which in practice means Chinese firms can't freely transfer the know-how.
July 2025: China's Ministry of Commerce required licences to export technology for high-density LFP and LMFP cathode materials. (Benchmark Minerals)
October 2025: A wider package added third-generation LFP technology, key cathode materials and manufacturing equipment such as rotary kilns, spray dryers and furnaces. (DGAP, ESS News)
November 2025: China suspended the October package until 10 November 2026. But the fourth-generation LFP technology licence, the one that matters most, was not part of that suspension. (Saur Energy)
Only the high end is targeted. The material controls apply to LFP with compaction density above 2.5 g/cc. Chinese firms can still sell ordinary LFP material abroad. (Volt Insight)
Why this matters so much: China controls close to 100% of global LFP cathode output and 75% of the purified phosphoric acid needed to make it. LFP also powers over 90% of grid-scale storage worldwide. (LFP Battery Tech, citing IEA)
What it means for GFCL: Most of GFCL's battery portfolio is chemistry-agnostic. LiPF₆, electrolytes and PVDF are used in both LFP and NMC cells, so the China rules don't touch them directly. Only the LFP cathode product is exposed. There, the effect could even be positive, since buyers now badly want a non-Chinese LFP supplier with its own process.
Two questions the call did not answer, and investors should ask: Does GFCL's LFP process rely on Chinese equipment that now needs export licences? And can its LFP reach the high compaction density that cell makers now demand?
Yes, in the near term, domestic demand for battery chemicals will come later than it would have without China's curbs. But the picture is more nuanced than "plans halted", and the long-term effect on GFCL could even be positive.
What each company has actually done:
Company | What happened | Source |
|---|---|---|
| JSW Group | Put its LFP cell factory on hold after failing to secure an LFP technology tie-up | Cartoq/Mint, Business Today |
| Reliance Industries | Bloomberg reported in January 2026 that Reliance paused cell manufacturing after its Chinese partner Hithium withdrew, and refocused on BESS assembly. Reliance has since said its battery plans remain on track | Deccan Herald/Reuters, Cartoq |
| Amara Raja | Not halted. Its tech deal with China's Gotion ran into difficulties, so it is developing technology in-house. Initial 2027 production will focus on NMC cells | Batteries International, Business Today |
| Tata (Agratas) | Going solo on a 20 GWh cell plant at Sanand, Gujarat | Business Today |
| Exide Industries | Flagged delays to its LFP cell plant | Business Today |
Meanwhile, India keeps importing. Lithium-ion cell imports jumped 64% to ₹41,667 crore in FY26, with China supplying 84%. (Business Today)
The short-term hit is real. Electrolytes, LFP cathode and anode materials need Indian cell factories as customers. Fewer and later Indian cell plants means a smaller domestic market for these products in FY27–FY29.
But the "what if there were no ban" scenario isn't as rosy as it looks. If Indian groups had licensed Chinese cell technology, the cell plants would have come up faster. However, Chinese technology licences usually come with a Chinese-qualified supply chain. The materials would likely have flowed from Chinese vendors too, leaving little room for Indian suppliers like GFCL.
Home-grown technology changes that. Companies building their own cell technology, like Amara Raja and Tata's Agratas, are free to qualify local suppliers. They also need them to meet domestic value-addition targets under the cell PLI. That makes an integrated Indian player like GFCL a natural partner.
Exports cushion the delay. GFCL's lead product, LiPF₆, is sold to global electrolyte makers and doesn't depend on Indian cells at all.
Our view: China's curbs delay GFCL's India opportunity by a year or two. But they may improve GFCL's share of that opportunity once it arrives.
The India BESS opportunity for GFCL is a FY28–FY30 story, not an FY27 one. The data explains why:
India's 2026 BESS tender pipeline totals about 260 GWh, but only 2 GWh of domestic cell capacity is operational, enough for less than 1% of it. (Energy-Storage.News)
Wood Mackenzie estimates locally made cells cost 25–40% more than imports, and India is 10–15 years from a globally competitive, self-sufficient cell industry. (SME Street)
So how does GFCL get business? Three routes:
Exports now. LiPF₆ goes to global electrolyte makers, whose cells end up in BESS projects worldwide, including in India. GFCL earns from BESS growth even when the cells are imported.
Indian cell makers later. GFCL is already qualifying its electrolytes with Indian cell manufacturers. Being qualified early means being first in line when their plants ramp up.
Localisation rules over time. BESS projects need at least 20% domestic content to receive government viability gap funding (VGF). (Energy-Storage.News) The solar sector shows where this can go: India mandated domestically made solar cells in key projects from June 2026 under ALMM List-II. A similar push for battery cells is widely expected, though not yet announced.
The biggest upcoming trigger is a new incentive scheme for battery components. In late August 2026, Bloomberg reported India is nearing rollout of a scheme worth up to ₹13,000 crore for five components: cathode and anode active materials, electrolytes, separator film and copper foil. (Business Standard) Earlier reports had put it at ₹12,000 crore. As of this writing, we could not confirm formal Cabinet approval.
Three of GFCL's five battery products (cathode, anode, electrolytes) fall squarely in the scheme's categories, and LiPF₆ feeds into electrolytes. The design also favours deep, integrated manufacturing. An official said the government doesn't want companies importing end products or doing only last-stage processing and claiming incentives. (Electronics For You) GFCL makes its own fluorine chemistry in-house, which fits that requirement well.
Other tailwinds already in place:
Policy | What it does |
|---|---|
| BESS viability gap funding, tranche 2 | ₹5,400 crore approved on 14 May 2026 to support 30 GWh of new storage capacity (IISE) |
| 20% domestic content rule | Required for BESS projects to get VGF support |
| ACC cell PLI | ₹18,100 crore scheme for 50 GWh of domestic cell capacity (MHI) |
| Customs duty relief | Budget 2026–27 removed duty on capital goods for lithium-ion cell manufacturing (SJ Exim) |
| Transmission charge waiver | Full ISTS waiver for BESS co-located with renewables and commissioned by 30 June 2028 |
One more external factor: China has introduced a domestic consumption tax on lithium-ion batteries, 2% from September 2026 rising to 4% from September 2027. (Saur Energy) It is a small but real shift in China's cost picture.
Slow Indian cell build-out. Under the existing cell PLI, only 1.4 GWh (2.8%) of the 50 GWh target had been commissioned. (pv magazine India) Domestic chemical demand depends on this improving.
Timeline slippage. Qualification in batteries is slow, and GFCL's ₹100 crore quarterly revenue target for Q4 FY27 is the first real test.
Funding gap after Oman. Watch how the lost ₹1,200 crore of OIA funding is replaced.
Chinese price competition. Chinese oversupply keeps material prices low, squeezing margins for new entrants.
Inverted duty structure. Industry says finished battery products can sometimes be imported at a lower effective duty than the raw materials needed to make them in India.
Component PLI not yet notified. The final scheme's size, conditions and eligibility could differ from reports.
Milestones to watch over the next 2–3 quarters: Q2 revenue recognition of CIF shipments, PVDF qualification, the component PLI notification, LFP cathode commercialisation, and any new cell-maker supply agreements.
GFCL EV is still in its "invest and qualify" phase. Today it earns ₹20–30 crore a quarter, targets ₹100 crore+ by Q4 FY27, and expects the real ramp from FY28.
China's LFP curbs and the resulting pullbacks by Indian cell makers delay the domestic opportunity. They do not break GFCL's story. Its lead product, LiPF₆, sells globally, most of its portfolio works across battery chemistries, and a world wary of Chinese dependence is looking for exactly the kind of integrated, non-Chinese supplier GFCL is trying to become. If the component PLI is notified on the reported terms, it adds a meaningful policy boost.
For investors, the next 2–3 quarters of execution will show whether the battery bet is on track.
Disclaimer: This blog is for information purposes only and is not investment advice. It is based on GFCL's Q1 FY27 earnings call transcript (12 August 2026) and publicly available sources as of September 2026. Policy details, especially the proposed battery component incentive scheme, may change. Please do your own research or consult a financial adviser before making investment decisions.